A Pilot Study for Pharmacokinetic Parameter of Colchicine in Patient Taking Rifampin
NCT01932268 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 2
Last updated 2013-08-30
Summary
The purpose of this study is to examine the colchicine concentration before and after the administration of rifampicin.
Conditions
Interventions
- DRUG
-
Rifampicin
single arm : check a change of Colchicine concentrations from basline at 1,2,4,8,24 hours after Rifampicin administration
Sponsors & Collaborators
-
Seoul National University Hospital
lead OTHER
Study Design
- Allocation
- NA
- Purpose
- BASIC_SCIENCE
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 19 Years
- Max Age
- 80 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2011-01-31
- Primary Completion
- 2011-12-31
- Completion
- 2011-12-31
More Related Trials
-
TMC207-C202: Study to Evaluate Bactericidal Activity of Multiple Oral Doses of TMC207 in Subjects With Sputum-Smear Positive Tuberculosis
NCT00523926 ·Status: COMPLETED ·Phase: PHASE2
-
Study to Investigate the Safety, Tolerability, and Pharmacokinetics of DSTA4637S in Participants With Staphylococcus Aureus Bacteremia Receiving Standard-of-Care (SOC) Antibiotics
NCT03162250 ·Status: COMPLETED ·Phase: PHASE1
-
Therapeutic Drug Monitoring for Linezolid in the Treatment of Rifampin-resistant Tuberculosis
NCT06590428 ·Status: RECRUITING ·Phase: NA
-
Probability of Target Attainment With Standard Intermittent Bolus Administration of Cefazolin in Patients With Complicated Infections Caused by Staphylococcus Aureus
NCT04503252 ·Status: COMPLETED
-
COVID-19 Vaccination and Breakthrough Infections Among Persons With Immunocompromising Conditions in the United States
NCT05020145 ·Status: COMPLETED
-
Early Infectious Disease Consultations in Staphylococcus Aureus Bacteremia
NCT00622882 ·Status: UNKNOWN ·Phase: NA
-
Treatment Shortening of MDR-TB Using Existing and New Drugs
NCT02619994 ·Status: COMPLETED ·Phase: PHASE2
-
Safety & Efficacy of an Antibacterial Protein Molecule Applied Topically to the Nostrils of Volunteers and Patients
NCT01746654 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Special Investigation of Clarith/Klaricid in Patients With Non-tuberculous Mycobacterial Pulmonary Infections
NCT01097005 ·Status: COMPLETED
-
Collect Clinical Data in Chinese Patients Received CUBICIN Treatment for Actual Usage in Clinical Practice
NCT01212601 ·Status: COMPLETED
-
Investigation of the Correlation Between Plasma Concentration of Linezolid Antibiotic and Treatment Response and Adverse Reactions
NCT03126890 ·Status: UNKNOWN
-
Multiple-Center Retrospective Study of Severe and Critical COVID-19 in Shanghai
NCT05422963 ·Status: UNKNOWN
-
Retapamulin for Reducing MRSA Nasal Carriage
NCT01461668 ·Status: COMPLETED ·Phase: PHASE4
-
Human Immunity Against Staphylococcus Aureus Skin Infection
NCT02262819 ·Status: COMPLETED ·Phase: PHASE1
-
Whole Blood Bactericidal Activity Against Mycobacterium Tuberculosis of Pyrazinamide Plus Allopurinol in Healthy Volunteers
NCT02700347 ·Status: COMPLETED ·Phase: PHASE1
-
Adjunctive Rifampin for the Treatment of Prosthetic Valve Endocarditis Due to S. Aureus
NCT07253688 ·Status: RECRUITING ·Phase: PHASE3
-
Study the Safety and Efficacy of PTK 0796 in Patients With Complicated Skin and Skin Structure Infection (CSSSI)
NCT00865280 ·Status: TERMINATED ·Phase: PHASE3
-
A Study to Investigate the Transmission and Burden of PVL-MRSA in Households in Sri Lanka
NCT04884958 ·Status: UNKNOWN
-
Virulence Determinants in S Aureus Bacteremia
NCT00319826 ·Status: COMPLETED
-
Antibiotics and Vaccine Immune Responses Study
NCT06148025 ·Status: RECRUITING ·Phase: PHASE4
-
PK/PD of Ertapenem In Patients With TB
NCT01730664 ·Status: COMPLETED ·Phase: PHASE2
-
SARS-CoV-2 Infection Among Healthcare Workers
NCT05680896 ·Status: UNKNOWN
-
Drug Interaction Study Between Linezolid and Clarithromycin in Tuberculosis Patients
NCT01521364 ·Status: COMPLETED ·Phase: PHASE4
-
Ertapenem Study in Pediatric Patients Who Have Urinary Tract Infections, Skin Infections or Community-acquired Pneumonia (0826-036)
NCT00451386 ·Status: COMPLETED ·Phase: PHASE2
-
Evaluation of CL Detect™ Rapid Test to Detect Cutaneous Leishmaniasis
NCT01865032 ·Status: COMPLETED